MALCOLM HOENLEIN - Corporate Board Profile

TG THERAPEUTICS, INC.

Filing Date	Source Excerpt
2004-07-28	Malcolm Hoenlein was appointed to the Board of Directors in July 2004. Since January 2001, he has also served as a director of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX). Mr. Hoenlein currently serves as the Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, a position he has held since 1986. He also serves as a director of Bank Leumi. Mr. Hoenlein received his B.A. from Temple University and his M.A. from the University of Pennsylvania. Following the appointment of Messrs. Steinhart, Herskowitz, and Hoenlein to the Board of Directors in July 2004, the Board replaced each of the existing Audit Committee members with such individuals. The Board has determined that each of Messrs. Steinhart, Hoenlein and Herskowitz meet the independence and other requirements to serve on the Audit Committee under applicable securities laws and rules and listing standards of the American Stock Exchange. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and Tanen. The Compensation Committee is currently comprised of Messrs. Steinhart, Hoenlein, Herskowitz and Dr. Weiser.
2005-10-21	Malcolm Hoenlein was appointed to the Board of Directors in July 2004. Since January 2001, he has also served as a director of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX). Mr. Hoenlein currently serves as the Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, a position he has held since 1986. He also serves as a director of Bank Leumi. The Board appointed Messrs. Steinhart, Herskowitz, and Hoenlein to the Audit Committee to replace Messrs. Tanen and Kazam and Dr. Weiser. The Board created a Nominating Committee, comprised of Messrs. Herskowitz, Hoenlein, Steinhart and David M. Tanen, who resigned from the Board in September 2005. The Compensation Committee is currently comprised of Messrs. Steinhart, Hoenlein, Herskowitz and Dr. Weiser.
2006-11-17	Malcolm Hoenlein was appointed to our Board of Directors in July 2004. Since January 2001, he has also served as a director of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX). Mr. Hoenlein currently serves as the Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, a position he has held since 1986. He also serves as a director of Bank Leumi. Mr. Hoenlein received his B.A. from Temple University and his M.A. from the University of Pennsylvania.
2007-04-30	Malcolm Hoenlein was appointed to our Board of Directors in July 2004. ... The Board of Directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership for each of the Board committees: Audit Committee Messrs. Herskowitz, Hoenlein and Steinhart (Chair) Compensation Committee Messrs. Herskowitz, Hoenlein, Steinhart and Dr. Weiser Nominating and Governance Committee Messrs. Herskowitz, Hoenlein and Steinhart ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2006: Malcolm Hoenlein Fees Earned or Paid in Cash $3,500 Option Awards $32,022 All Other Compensation $0 Total $35,522
2008-05-12	Malcolm Hoenlein was appointed to our Board of Directors in July 2004. ... Audit Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... Compensation Committee members: Messrs. Herskowitz, Hoenlein, Steinhart and Weiser (Chair). ... Nominating and Governance Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2007: Malcolm Hoenlein total compensation $32,948.
2009-10-29	Malcolm Hoenlein was appointed to our Board of Directors in July 2004. Since January 2001, he is also a director of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2008: Malcolm Hoenlein (3) $6,000 $14,767 - $20,767 ... Nominating and Governance: Messrs. Herskowitz, Hoenlein and Steinhart (Chair)